Wells Fargo’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-30,941
Closed -$731K 7768
2023
Q4
$731K Buy
30,941
+10,319
+50% +$184K ﹤0.01% 3629
2023
Q3
$307K Sell
20,622
-20,259
-50% -$269K ﹤0.01% 4076
2023
Q2
$448K Buy
40,881
+40,262
+6,504% +$375K ﹤0.01% 4029
2023
Q1
$5.4K Buy
619
+82
+15% +$656 ﹤0.01% 6031
2022
Q4
$3.37K Sell
537
-162
-23% -$616 ﹤0.01% 5879
2022
Q3
$3K Sell
699
-10
-1% -$36 ﹤0.01% 6107
2022
Q2
$3K Sell
709
-9,150
-93% -$21.9K ﹤0.01% 6253
2022
Q1
$31K Sell
9,859
-21,122
-68% -$66.5K ﹤0.01% 5860
2021
Q4
$105K Buy
30,981
+26,784
+638% +$102K ﹤0.01% 5606
2021
Q3
$16K Sell
4,197
-40,127
-91% -$158K ﹤0.01% 6053
2021
Q2
$194K Sell
44,324
-180,618
-80% -$801K ﹤0.01% 5045
2021
Q1
$1.02M Buy
224,942
+44,161
+24% +$238K ﹤0.01% 4233
2020
Q4
$1.04M Buy
180,781
+129,758
+254% +$982K ﹤0.01% 4000
2020
Q3
$369K Sell
51,023
-13,067
-20% -$69.9K ﹤0.01% 4571
2020
Q2
$224K Buy
64,090
+18,782
+41% +$54.2K ﹤0.01% 4839
2020
Q1
$67K Sell
45,308
-3,089
-6% -$5.19K ﹤0.01% 5242
2019
Q4
$95K Sell
48,397
-38,656
-44% -$145K ﹤0.01% 5323
2019
Q3
$446K Buy
87,053
+16,595
+24% +$100K ﹤0.01% 4454
2019
Q2
$504K Sell
70,458
-69,477
-50% -$787K ﹤0.01% 4375
2019
Q1
$1.86M Sell
139,935
-1,921
-1% -$20.4K ﹤0.01% 3417
2018
Q4
$1.12M Buy
141,856
+4,063
+3% +$38.7K ﹤0.01% 3759
2018
Q3
$1.53M Buy
137,793
+45,929
+50% +$570K ﹤0.01% 3635
2018
Q2
$1.23M Buy
91,864
+39,141
+74% +$490K ﹤0.01% 3842
2018
Q1
$685K Buy
52,723
+13,577
+35% +$169K ﹤0.01% 4185
2017
Q4
$360K Buy
39,146
+38,646
+7,729% +$330K ﹤0.01% 4632
2017
Q3
$4K Buy
+500
New +$3.38K ﹤0.01% 6085

Other funds holding CBAY